Stock Analysis

Maruzen CHI HoldingsLtd First Quarter 2025 Earnings: EPS: JP¥16.04 (vs JP¥15.61 in 1Q 2024)

TSE:3159
Source: Shutterstock

Maruzen CHI HoldingsLtd (TSE:3159) First Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥46.4b (flat on 1Q 2024).
  • Net income: JP¥1.48b (up 2.7% from 1Q 2024).
  • Profit margin: 3.2% (up from 3.1% in 1Q 2024).
  • EPS: JP¥16.04 (up from JP¥15.61 in 1Q 2024).
earnings-and-revenue-history
TSE:3159 Earnings and Revenue History June 17th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Maruzen CHI HoldingsLtd shares are up 1.2% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on Maruzen CHI HoldingsLtd's balance sheet health.

Valuation is complex, but we're helping make it simple.

Find out whether Maruzen CHI HoldingsLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're helping make it simple.

Find out whether Maruzen CHI HoldingsLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com